Agios Pharmaceuticals, Inc

(NASDAQ:AGIO)

Latest On Agios Pharmaceuticals, Inc (AGIO):

Date/Time Type Description Signal Details
2023-05-24 13:19 ESTNewsAgios Pharmaceuticals: Good Execution, A Good Deal Of Cash, Some HurdlesN/A
2023-05-04 22:01 ESTNewsAgios Pharmaceuticals, Inc. 2023 Q1 - Results - Earnings Call PresentationN/A
2023-05-04 22:01 ESTNewsAgios Pharmaceuticals, Inc. (AGIO) Q1 2023 Earnings Call TranscriptN/A
2023-05-04 09:00 ESTNewsAgios Pharmaceuticals GAAP EPS of -$1.47 beats by $0.23, revenue of $5.6M beats by $0.37MN/A
2023-05-03 20:46 ESTNewsAgios Pharmaceuticals Q1 2023 Earnings PreviewN/A
2023-02-24 01:00 ESTNewsAgios Pharmaceuticals, Inc. (AGIO) Q4 2022 Earnings Call TranscriptN/A
2023-02-23 11:31 ESTNewsAgios Pharmaceuticals GAAP EPS of -$4.23 beats by $2.06, revenue of $14.24M beats by $0.35MN/A
2023-02-22 09:46 ESTNewsAgios Pharma: Multiple Growth Catalysts If Pyrukynd Conversions Pull ThroughN/A
2023-01-11 19:46 ESTNewsAgios Pharmaceuticals (AGIO) presents at 41st Annual J.P. Morgan Healthcare Conference - SlideshowN/A
2022-12-12 09:07 ESTNewsAgios rare blood disorder drug Pyrukynd sustains benefits in patients in long term dataN/A
2022-11-17 17:06 ESTNewsAgios Pharmaceuticals upgraded to neutral at Goldman Sachs on Pyrukynd outlookN/A
2022-11-12 00:39 ESTNewsAgios granted EU approval for Pyrukynd in pyruvate kinase deficiencyN/A
2022-11-04 15:26 ESTNewsAgios Pharmaceuticals, Inc. (AGIO) Q3 2022 Earnings Call TranscriptN/A
2022-11-04 15:26 ESTNewsAgios Pharmaceuticals, Inc. 2022 Q3 - Results - Earnings Call PresentationN/A
2022-11-03 22:53 ESTNewsAgios Pharmaceuticals GAAP EPS of -$1.49 beats by $0.27, revenue of $3.52M misses by $1.72MN/A
2022-10-30 23:18 ESTNewsAgios Pharmaceuticals: A Big Year On The HorizonN/A
2022-10-27 21:23 ESTNewsAgios sells its rights to royalties on U.S. sales of cancer drug Tibsovo for $131.8MN/A
2022-09-19 18:38 ESTNewsAgios appoints Cecilia Jones as finance chiefN/A
2022-09-16 22:56 ESTNewsAgios Pyrukynd for rare blood disorder gets EMA panel backing for approval in EUN/A
2022-09-07 13:53 ESTNewsAgios CFO Jonathan Biller to quitN/A
2022-09-01 18:52 ESTNewsAgios adds more than 13% after Novo deal to acquire rival FormaN/A
2022-08-07 19:20 ESTNewsAgios Pharmaceuticals, Inc. (AGIO) CEO Jackie Fouse on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-07 19:20 ESTNewsAgios Pharmaceuticals, Inc. 2022 Q2 - Results - Earnings Call PresentationN/A
2022-08-04 23:04 ESTNewsAgios stock rises as Q2 sees new drug Pyrukynd bring in revenueN/A
2022-08-04 07:32 ESTNewsAgios Pharmaceuticals GAAP EPS of -$1.68 beats by $0.07N/A
2022-07-27 15:35 ESTNewsAgios gains as blood disorder therapy draws positive viewsN/A
2022-07-26 12:48 ESTNewsAgios Pharmaceuticals Is A Buy On Coming Revenue RampN/A
2022-07-12 22:36 ESTNewsAgios Pharmaceuticals hires new CEON/A
2022-07-12 22:36 ESTNewsAgios Pharmaceuticals appoints new board chair, CEON/A
2022-06-18 02:50 ESTNewsAgios Pharmaceuticals (AGIO) Presents At EHA 2022 Conference - SlideshowN/A
2022-05-18 02:34 ESTNewsAgios chief scientific officer to depart amid layoffs as company pivots to genetic diseasesN/A
2022-05-10 23:23 ESTNewsAgios: Approved Product, Upcoming CatalystsN/A
2022-05-10 01:38 ESTNewsAgios Pharmaceuticals, Inc. 2022 Q1 - Results - Earnings Call PresentationN/A
2022-05-05 20:57 ESTNewsAgios Pharmaceuticals GAAP EPS of -$1.74 beats by $0.07, revenue of $0.83M misses by $1.88MN/A
2022-05-05 20:57 ESTNewsAgios Pharmaceuticals, Inc. (AGIO) CEO Jackie Fouse on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-04 22:11 ESTNewsAgios Pharmaceuticals Q1 2022 Earnings PreviewN/A
2022-02-25 04:07 ESTNewsAgios Pharmaceuticals, Inc. 2021 Q4 - Results - Earnings Call PresentationN/A
2022-02-25 04:06 ESTNewsAgios Pharmaceuticals, Inc. (AGIO) CEO Jackie Fouse on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-24 08:21 ESTNewsAgios Pharmaceuticals Q4 2021 Earnings PreviewN/A
2022-02-24 08:20 ESTNewsAgios Pharmaceuticals GAAP EPS of -$1.81 misses by $0.12N/A
2022-02-23 12:21 ESTNewsAgios Pharmaceuticals With FDA Approval Is A BuyN/A
2022-02-19 06:37 ESTNewsAgios Pharmaceuticals' mitapivat approved by FDA for pyruvate kinase deficiencyN/A
2022-02-19 06:36 ESTNewsAgios vindicated with FDA approval for Pyrukynd - H.C. WainwrightN/A
2022-02-18 08:40 ESTNewsAgios Pyrukynd for rare blood disorder gets US FDA approvalN/A
2022-01-20 15:39 ESTNewsAgios Before The February PDUFAN/A
2021-12-14 09:40 ESTNewsAgios presents mitapivat long-term data in PK deficiency at ASH 2021N/A
2021-11-04 03:28 ESTNewsAgios Pharmaceuticals, Inc. (AGIO) CEO Dr. Jackie Fouse on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-04 03:28 ESTNewsAgios Pharmaceuticals, Inc. 2021 Q3 - Results - Earnings Call PresentationN/A
2021-11-03 07:29 ESTNewsAgios Pharmaceuticals EPS beats by $1.46N/A
2021-11-02 11:38 ESTNewsAgios Pharmaceuticals Q3 2021 Earnings PreviewN/A

About Agios Pharmaceuticals, Inc (AGIO):

Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers TIBSOVO (ivosidenib), an oral targeted inhibitor for treating adult patients with relapsed or refractory acute myeloid leukemia (R/R AML), as well as to treat patients with newly diagnosed AML; and IDHIFA (enasidenib), an oral targeted inhibitor for patients with R/R AML and an isocitrate dehydrogenase 2 mutation. It is also developing TIBSOVO, which has completed Phase II clinical trials to treat IC eligible frontline AML; that is in Phase III clinical trials for treating IC ineligible frontline AML; and that is in Phase III clinical trials for the treatment of cholangiocarcinoma, as well as in early stage clinical development to treat glioma and solid tumors. In addition, the company is developing IDHIFA, which has completed Phase II clinical study for treating IC eligible frontline AML; and that is in Phase I/II clinical trials for the treatment of IC ineligible frontline AML. Further, it is developing mitapivat, which is in Phase III clinical trials to treat pyruvate kinase deficiency, as well as in Phase II clinical study for treating thalassemia and sickle cell disease; vorasidenib (AG-881) that is in Phase I clinical trials for the treatment of solid tumors, including glioma; AG-270, which is in Phase I dose-escalation trial to treat methylthioadenosine phosphorylase deleted tumors; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is based in Cambridge, Massachusetts.

AGIO Quotes by TradingView

See Advanced Chart

General

  • Name Agios Pharmaceuticals, Inc
  • Symbol AGIO
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 562
  • Fiscal Year EndDecember
  • IPO Date2013-07-24
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.agios.com
View More

Valuation

  • Forward PE 8.1
  • Price/Sales (Trailing 12 Mt.) 17.51
  • Price/Book (Most Recent Quarter) 8.98
  • Enterprise Value Revenue 15.36
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$6.07
  • Next Year EPS Estimate -$6.10
  • Next Quarter EPS Estimate -$1.29
  • Profit Margin -161%
  • Operating Margin -156%
  • Return on Assets -23%
  • Return on Equity -63%
  • Revenue 203.2 million
  • Earnings Per Share -$6.67
  • Revenue Per Share $2.95
  • Gross Profit -167079000
  • Quarterly Earnings Growth 24.3%
View More

Highlights

  • Market Capitalization 3.38 billion
  • EBITDA -399112000
  • PE Ratio 1.63
  • Analyst Target Price $64.89
  • Book Value Per Share $5.77
View More

Share Statistics

  • Shares Outstanding 69.36 million
  • Shares Float 61.75 million
  • % Held by Insiders 1133%
  • % Held by Institutions 92.34%
  • Shares Short 5.82 million
  • Shares Short Prior Month 5.68 million
  • Short Ratio 8.4
  • Short % of Float 11%
  • Short % of Shares Outstanding 8%
View More

Technicals

  • Beta 1.62
  • 52 Week High $58.93
  • 52 Week Low $32.47
  • 50 Day Moving Average 50.87
  • 200 Day Moving Average 42.95
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Agios Pharmaceuticals, Inc (AGIO) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Agios Pharmaceuticals, Inc (AGIO) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$44.05 million-$1.41-$1.31-7.96%
2020-09-302020-11-05$34.71 million-$1.43-$1.36-5.47%
2020-06-302020-07-30$N/A-$1.31-$1.363.72%
2020-03-312020-04-30$N/A-$0.59-$1.6463.94%
2019-12-312020-02-13$35.44 million-$1.60-$1.684.94%
2019-09-302019-10-31$26.02 million-$1.81-$1.81-0.22%
2019-06-302019-08-01$26.22 million-$1.87-$1.70-9.89%
2019-03-312019-05-02$30.23 million-$1.59-$1.759.24%
2018-12-312019-02-14$30.01 million-$1.58-$1.664.62%
2018-09-302018-11-01$15.2 million-$1.63-$1.62-0.73%
2018-06-302018-08-02$40.41 million-$1.19-$1.5523.07%
2018-03-312018-05-04$8.76 million-$1.63-$1.651.41%
2017-12-312018-02-14$9.8 million-$1.81-$1.61-12.63%
2017-09-302017-11-01$11.36 million-$1.59-$1.7810.46%
2017-06-302017-08-08$11.35 million-$1.78-$1.57-13.53%
2017-03-312017-05-04$10.51 million-$1.56-$1.8013.19%
2016-12-312017-02-16$22.65 million-$1.34-$1.5111.38%
2016-09-302016-11-03$8.99 million-$1.63-$1.51-8.2%
2016-06-302016-08-04$6.98 million-$1.47-$1.30-12.77%
2016-03-312016-05-05$31.28 million-$0.61-$0.9334.47%
2015-12-312016-02-18$6.22 million-$1.08-$0.53-102.21%
2015-09-302015-11-05$5.48 million-$1.07-$0.88-21.59%
2015-06-302015-08-06$13.22 million-$0.85-$0.46-84.78%
2015-03-312015-05-07$34.2 million-$0.13-$0.9285.87%
2014-12-312015-02-17$14.64 million-$0.76-$0.58-31.03%
2014-09-302014-11-07$33.9 million$0.10-$0.52119.23%
2014-06-302014-08-07$8.41 million-$0.54-$0.40-35%
2014-03-312014-05-08$8.41 million-$0.39-$0.37-5.41%
2013-12-312014-03-06$6.74 million-$0.40-$0.34-17.65%
2013-09-302013-11-07$6.27 million-$0.47-$0.29-62.07%
2013-06-302013-09-05$6.27 million-$2.80-$0.32-775%

Agios Pharmaceuticals, Inc (AGIO) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Agios Pharmaceuticals, Inc (AGIO) Chart:

Agios Pharmaceuticals, Inc (AGIO) News:

Below you will find a list of latest news for Agios Pharmaceuticals, Inc (AGIO) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Agios Pharmaceuticals, Inc (AGIO) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-05-1512.50CALL0 14477.13TRUE00
2026-05-15150CALL0 0433.7TRUE00
2026-05-1517.510.26CALL0 3367.97TRUE00
2026-05-15200CALL0 12284.45TRUE00
2026-05-1522.50CALL0 8151.15TRUE00
2026-05-15253.2CALL10 648100.6TRUE0.70.28
2026-05-15300.25CALL29 82576.5FALSE-0.02-0.07
2026-05-15350.05CALL2 819116.27FALSE0.050
2026-05-15400.01CALL0 1033191.28FALSE00
2026-05-15450CALL0 97278.81FALSE00
2026-05-15500.1CALL3 44280.9FALSE0.10
2026-05-15550CALL0 15647.19FALSE00
2026-05-15600CALL0 22579.11FALSE00
2026-05-15650CALL0 8490.09FALSE00
2026-05-1512.50PUT0 4508.55FALSE00
2026-05-15150PUT0 15407.84FALSE00
2026-05-1517.50PUT0 1322.22FALSE00
2026-05-15200PUT0 321212.74FALSE00
2026-05-1522.50.2PUT1 126162.53FALSE0.20
2026-05-15250.05PUT0 22092.05FALSE00
2026-05-15302.1PUT1 60355.88TRUE-0.4-0.16
2026-05-15350PUT0 3830TRUE00
2026-05-15400PUT0 00TRUE00
2026-05-15450PUT0 00TRUE00
2026-05-15500PUT0 00TRUE00
2026-05-15550PUT0 00TRUE00
2026-05-15600PUT0 00TRUE00
2026-05-15650PUT0 00TRUE00
2026-06-1817.50CALL0 1119.33TRUE00
2026-06-18200CALL0 085.06TRUE00
2026-06-1822.50CALL0 455.05TRUE00
2026-06-18253.4CALL0 158.55TRUE00
2026-06-18301.55CALL1 13953.97FALSE0.380.32
2026-06-18350.24CALL0 30662.95FALSE00
2026-06-18400CALL0 187.61FALSE00
2026-06-18450CALL0 11105.28FALSE00
2026-06-18500CALL0 0122.87FALSE00
2026-06-1817.50PUT0 1115.9FALSE00
2026-06-18200PUT0 091.2FALSE00
2026-06-1822.50.4PUT0 21553.31FALSE00
2026-06-18250.79PUT0 7654.29FALSE00
2026-06-18303.16PUT0 5146.34TRUE00
2026-06-18350PUT0 00TRUE00
2026-06-18400PUT0 068.77TRUE00
2026-06-18450PUT0 00TRUE00
2026-06-18500PUT0 00TRUE00
2026-08-2112.50CALL0 0110TRUE00
2026-08-21150CALL0 198.24TRUE00
2026-08-2117.50CALL0 087.67TRUE00
2026-08-21200CALL0 380.38TRUE00
2026-08-2122.50CALL0 273.01TRUE00
2026-08-21250CALL0 33071.87TRUE00
2026-08-21302.7CALL0 82864.32FALSE00
2026-08-21351.9CALL2 12168.13FALSE0.20.12
2026-08-21400CALL0 11165.53FALSE00
2026-08-21450CALL0 9875.77FALSE00
2026-08-21500CALL0 284.99FALSE00
2026-08-2112.50PUT0 0116.2FALSE00
2026-08-21150PUT0 2295.24FALSE00
2026-08-2117.50PUT0 10083.46FALSE00
2026-08-21200PUT0 974.21FALSE00
2026-08-2122.50PUT0 569.83FALSE00
2026-08-21250PUT0 35366.69FALSE00
2026-08-21300PUT0 69264.57TRUE00
2026-08-21350PUT0 3663.07TRUE00
2026-08-21400PUT0 056.62TRUE00
2026-08-21450PUT0 00TRUE00
2026-08-21500PUT0 00TRUE00
2026-11-2012.50CALL0 087.31TRUE00
2026-11-20150CALL0 085.95TRUE00
2026-11-2017.50CALL0 079.54TRUE00
2026-11-20200CALL0 075.63TRUE00
2026-11-2022.58.75CALL5 573.72TRUE8.750
2026-11-20250CALL0 573.71TRUE00
2026-11-20300CALL0 272.75FALSE00
2026-11-20350CALL0 30670.91FALSE00
2026-11-20402.8CALL10 1973.72FALSE2.80
2026-11-20451.6CALL0 475.8FALSE00
2026-11-20500CALL0 880.02FALSE00
2026-11-2012.50PUT0 099.85FALSE00
2026-11-20150PUT0 078.07FALSE00
2026-11-2017.50PUT0 077.09FALSE00
2026-11-20201.7PUT0 773.54FALSE00
2026-11-2022.52.3PUT0 179.69FALSE00
2026-11-20250PUT0 26064.85FALSE00
2026-11-20300PUT0 167.23TRUE00
2026-11-20350PUT0 30068.49TRUE00
2026-11-20400PUT0 067.48TRUE00
2026-11-20450PUT0 068.69TRUE00
2026-11-20500PUT0 065.26TRUE00
2026-12-1812.50CALL0 099.14TRUE00
2026-12-18150CALL0 092.83TRUE00
2026-12-1817.50CALL0 087.28TRUE00
2026-12-18200CALL0 484.68TRUE00
2026-12-1822.50CALL0 783.11TRUE00
2026-12-18250CALL0 57878.99TRUE00
2026-12-18306.3CALL5 3208779.38FALSE6.30
2026-12-18354.27CALL0 26279.83FALSE00
2026-12-18400CALL0 6278.57FALSE00
2026-12-18450CALL0 33878.4FALSE00
2026-12-18502.1CALL0 92878.11FALSE00
2026-12-18550CALL0 977.69FALSE00
2026-12-18601.25CALL0 50675.57FALSE00
2026-12-18651.15CALL0 3686.9FALSE00
2026-12-1812.50.95PUT0 192.67FALSE00
2026-12-18150PUT0 287.4FALSE00
2026-12-1817.51.45PUT0 283FALSE00
2026-12-18200PUT0 4982.81FALSE00
2026-12-1822.50PUT0 789.08FALSE00
2026-12-18254.7PUT0 2990.95FALSE00
2026-12-18300PUT0 14079.74TRUE00
2026-12-18350PUT0 23876.29TRUE00
2026-12-18400PUT0 8076.38TRUE00
2026-12-18450PUT0 6077.12TRUE00
2026-12-18500PUT0 073.79TRUE00
2026-12-18550PUT0 072.44TRUE00
2026-12-18600PUT0 070.55TRUE00
2026-12-18650PUT0 070.83TRUE00
2027-01-1512.50CALL0 3595.7TRUE00
2027-01-15150CALL0 2889.13TRUE00
2027-01-1517.50CALL0 081.62TRUE00
2027-01-15200CALL0 479.26TRUE00
2027-01-1522.50CALL0 481.3TRUE00
2027-01-15250CALL0 3174.64TRUE00
2027-01-15300CALL0 11676.69FALSE00
2027-01-15350CALL0 4479.26FALSE00
2027-01-15400CALL0 4078.49FALSE00
2027-01-15450CALL0 2474.53FALSE00
2027-01-15500CALL0 7077.86FALSE00
2027-01-15551.75CALL0 883.3FALSE00
2027-01-15601.4CALL0 484.42FALSE00
2027-01-15651.05CALL0 1384.41FALSE00
2027-01-1512.50.8PUT0 689.2FALSE00
2027-01-15151.5PUT0 6580.08FALSE00
2027-01-1517.50PUT0 372.51FALSE00
2027-01-15200PUT0 675.54FALSE00
2027-01-1522.50PUT0 62171.53FALSE00
2027-01-15250PUT0 165173.92FALSE00
2027-01-15300PUT0 17976.16TRUE00
2027-01-15350PUT0 1776.27TRUE00
2027-01-15400PUT0 073.21TRUE00
2027-01-15450PUT0 075.93TRUE00
2027-01-15500PUT0 073.36TRUE00
2027-01-15550PUT0 069.35TRUE00
2027-01-15600PUT0 062.9TRUE00
2027-01-15650PUT0 065.53TRUE00
2028-01-2112.50CALL0 968.8TRUE00
2028-01-21150CALL0 1268.83TRUE00
2028-01-2117.50CALL0 069.85TRUE00
2028-01-21200CALL0 1167.55TRUE00
2028-01-2122.50CALL0 067.75TRUE00
2028-01-21250CALL0 966.51TRUE00
2028-01-21308.95CALL0 3664.83FALSE00
2028-01-21350CALL0 665.61FALSE00
2028-01-21400CALL0 1164.19FALSE00
2028-01-21450CALL0 766.53FALSE00
2028-01-21506.9CALL0 265FALSE00
2028-01-21550CALL0 066.22FALSE00
2028-01-21600CALL0 065.09FALSE00
2028-01-21650CALL0 166.31FALSE00
2028-01-2112.50PUT0 084.05FALSE00
2028-01-21150PUT0 070.06FALSE00
2028-01-2117.50PUT0 168.86FALSE00
2028-01-21200PUT0 267.47FALSE00
2028-01-2122.50PUT0 1765.81FALSE00
2028-01-21250PUT0 31366.92FALSE00
2028-01-21300PUT0 40864.85TRUE00
2028-01-21350PUT0 065.1TRUE00
2028-01-21400PUT0 064.7TRUE00
2028-01-21450PUT0 864.34TRUE00
2028-01-21500PUT0 1564.1TRUE00
2028-01-21550PUT0 066.02TRUE00
2028-01-21600PUT0 064.99TRUE00
2028-01-21650PUT0 066.98TRUE00

Latest AGIO Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST11$17.4
Jun 13, 2022 7:59 PM EST189$17.4
Jun 13, 2022 7:59 PM EST128$17.4
Jun 13, 2022 7:59 PM EST200$17.38
Jun 13, 2022 7:59 PM EST17$17.4

Agios Pharmaceuticals, Inc (AGIO) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520167148/0001193125-20-167148-index.htm
2019-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000021545719003331/0000215457-19-003331-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000031506619000835/0000315066-19-000835-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000031506620000791/0000315066-20-000791-index.htm
2020-08-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000031506620001684/0000315066-20-001684-index.htm
2019-10-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000083423719000203/0000834237-19-000203-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000083423720008047/0000834237-20-008047-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000090221919000091/0000902219-19-000091-index.htm
2020-01-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000090221920000008/0000902219-20-000008-index.htm
2019-01-31SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000093247119002231/0000932471-19-002231-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000093247119004832/0000932471-19-004832-index.htm
2019-11-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000110465919064171/0001104659-19-064171-index.htm
2019-11-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1439222/000110465919064173/0001104659-19-064173-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000110465920017624/0001104659-20-017624-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000110465920018297/0001104659-20-018297-index.htm
2018-11-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312518314801/0001193125-18-314801-index.htm
2018-11-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312518328948/0001193125-18-328948-index.htm
2018-12-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312518341083/0001193125-18-341083-index.htm
2018-12-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312518353307/0001193125-18-353307-index.htm
2019-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519003167/0001193125-19-003167-index.htm
2019-01-28SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000119312519018824/0001193125-19-018824-index.htm
2019-02-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519039198/0001193125-19-039198-index.htm
2019-02-14S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1439222/000119312519039513/0001193125-19-039513-index.htm
2019-02-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519051918/0001193125-19-051918-index.htm
2019-04-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519107805/0001193125-19-107805-index.htm
2019-04-18DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1439222/000119312519110870/0001193125-19-110870-index.htm
2019-04-18DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1439222/000119312519110887/0001193125-19-110887-index.htm
2019-05-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519133821/0001193125-19-133821-index.htm
2019-05-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519134882/0001193125-19-134882-index.htm
2019-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519148009/0001193125-19-148009-index.htm
2019-05-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519162771/0001193125-19-162771-index.htm
2019-06-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519164072/0001193125-19-164072-index.htm
2019-06-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519166109/0001193125-19-166109-index.htm
2019-08-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519209747/0001193125-19-209747-index.htm
2019-09-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519237824/0001193125-19-237824-index.htm
2019-09-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519258364/0001193125-19-258364-index.htm
2019-10-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519275491/0001193125-19-275491-index.htm
2019-10-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519279631/0001193125-19-279631-index.htm
2019-11-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519283514/0001193125-19-283514-index.htm
2019-11-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1439222/000119312519285887/0001193125-19-285887-index.htm
2019-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519288482/0001193125-19-288482-index.htm
2019-11-08424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1439222/000119312519288495/0001193125-19-288495-index.htm
2019-11-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519298670/0001193125-19-298670-index.htm
2019-12-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519309199/0001193125-19-309199-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520005857/0001193125-20-005857-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520006338/0001193125-20-006338-index.htm
2020-02-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520034263/0001193125-20-034263-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000119312520037796/0001193125-20-037796-index.htm
2020-02-19S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1439222/000119312520041964/0001193125-20-041964-index.htm
2020-04-16DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1439222/000119312520109284/0001193125-20-109284-index.htm
2020-04-16DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1439222/000119312520109288/0001193125-20-109288-index.htm
2020-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520127627/0001193125-20-127627-index.htm
2020-04-30POSASRPost-effective Amendment to an automatic shelf registration statementhttps://www.sec.gov/Archives/edgar/data/1439222/000119312520128793/0001193125-20-128793-index.htm
2020-04-30S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1439222/000119312520128809/0001193125-20-128809-index.htm
2020-05-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520155665/0001193125-20-155665-index.htm
2020-05-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520155682/0001193125-20-155682-index.htm
2020-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520167148/0001193125-20-167148-index.htm
2020-07-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520203351/0001193125-20-203351-index.htm
2020-09-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520240994/0001193125-20-240994-index.htm
2020-09-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520249634/0001193125-20-249634-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520286235/0001193125-20-286235-index.htm
2018-09-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919118050064/0001209191-18-050064-index.htm
2018-09-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919118050631/0001209191-18-050631-index.htm
2018-09-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919118050824/0001209191-18-050824-index.htm
2018-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919118054513/0001209191-18-054513-index.htm
2018-11-064/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919118057372/0001209191-18-057372-index.htm
2018-11-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919118057556/0001209191-18-057556-index.htm
2018-11-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919118059146/0001209191-18-059146-index.htm
2018-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919118064102/0001209191-18-064102-index.htm
2019-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119004950/0001209191-19-004950-index.htm
2019-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119004955/0001209191-19-004955-index.htm
2019-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119004961/0001209191-19-004961-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119007343/0001209191-19-007343-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119011483/0001209191-19-011483-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119011486/0001209191-19-011486-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119011489/0001209191-19-011489-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119011491/0001209191-19-011491-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119011494/0001209191-19-011494-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119011498/0001209191-19-011498-index.htm
2019-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119012942/0001209191-19-012942-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119013509/0001209191-19-013509-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119013515/0001209191-19-013515-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119013525/0001209191-19-013525-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119013531/0001209191-19-013531-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119013536/0001209191-19-013536-index.htm
2019-03-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119014933/0001209191-19-014933-index.htm
2019-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119016381/0001209191-19-016381-index.htm
2019-03-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119017738/0001209191-19-017738-index.htm
2019-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119020288/0001209191-19-020288-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119023072/0001209191-19-023072-index.htm
2019-04-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119024105/0001209191-19-024105-index.htm
2019-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119025785/0001209191-19-025785-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119033614/0001209191-19-033614-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119033616/0001209191-19-033616-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119033618/0001209191-19-033618-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119033620/0001209191-19-033620-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119033622/0001209191-19-033622-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119033625/0001209191-19-033625-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119033626/0001209191-19-033626-index.htm
2018-11-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1439222/000143922218000018/0001439222-18-000018-index.htm
2019-02-1410-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1439222/000143922219000004/0001439222-19-000004-index.htm
2019-05-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1439222/000143922219000009/0001439222-19-000009-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922219000011/0001439222-19-000011-index.htm
2019-08-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1439222/000143922219000017/0001439222-19-000017-index.htm
2019-10-3110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1439222/000143922219000021/0001439222-19-000021-index.htm
2019-11-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922219000023/0001439222-19-000023-index.htm
2019-11-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922219000025/0001439222-19-000025-index.htm
2019-12-053Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922219000027/0001439222-19-000027-index.htm
2019-12-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922219000028/0001439222-19-000028-index.htm
2019-12-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922219000030/0001439222-19-000030-index.htm
2020-01-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000002/0001439222-20-000002-index.htm
2020-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000003/0001439222-20-000003-index.htm
2020-02-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000005/0001439222-20-000005-index.htm
2020-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000006/0001439222-20-000006-index.htm
2020-02-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000008/0001439222-20-000008-index.htm
2020-02-1910-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1439222/000143922220000014/0001439222-20-000014-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000015/0001439222-20-000015-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000016/0001439222-20-000016-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000017/0001439222-20-000017-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000018/0001439222-20-000018-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000019/0001439222-20-000019-index.htm
2020-02-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000020/0001439222-20-000020-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000021/0001439222-20-000021-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000022/0001439222-20-000022-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000023/0001439222-20-000023-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000024/0001439222-20-000024-index.htm
2020-02-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000025/0001439222-20-000025-index.htm
2020-02-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000026/0001439222-20-000026-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000027/0001439222-20-000027-index.htm
2020-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000028/0001439222-20-000028-index.htm
2020-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000029/0001439222-20-000029-index.htm
2020-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000030/0001439222-20-000030-index.htm
2020-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000031/0001439222-20-000031-index.htm
2020-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000032/0001439222-20-000032-index.htm
2020-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000033/0001439222-20-000033-index.htm
2020-04-3010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1439222/000143922220000039/0001439222-20-000039-index.htm
2020-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000041/0001439222-20-000041-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000049/0001439222-20-000049-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000050/0001439222-20-000050-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000051/0001439222-20-000051-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000052/0001439222-20-000052-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000053/0001439222-20-000053-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000054/0001439222-20-000054-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000055/0001439222-20-000055-index.htm
2020-07-3010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1439222/000143922220000059/0001439222-20-000059-index.htm
2020-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000061/0001439222-20-000061-index.htm
2020-10-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000063/0001439222-20-000063-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1439222/000143922220000069/0001439222-20-000069-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000156223019000005/0001562230-19-000005-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000156223020000005/0001562230-20-000005-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000162828019007955/0001628280-19-007955-index.htm
2019-04-26CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1439222/999999999719003422/9999999997-19-003422-index.htm
2019-04-26CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1439222/999999999719003444/9999999997-19-003444-index.htm
2019-07-16CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1439222/999999999719006154/9999999997-19-006154-index.htm

Agios Pharmaceuticals, Inc (AGIO) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Agios Pharmaceuticals, Inc (AGIO). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1133%
Institutional Ownership: 9234%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-09-28Carman AlensonPrincipal Accounting OfficerSell152.0076.4511,620.400.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119011483/0001209191-19-011483-index.htm
2020-02-16David P SchenkeinDirectorBuy8,125.00105,692.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000015/0001439222-20-000015-index.htm
2020-02-22David P SchenkeinDirectorBuy2,775.00105,933.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000022/0001439222-20-000022-index.htm
2020-04-13Christopher BowdenChief Medical OfficerBuy5,280.0010,598.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000028/0001439222-20-000028-index.htm
2019-03-01Steven L. HoerterChief Commercial OfficerSell5,000.0066.01330,050.0010,941.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119016381/0001209191-19-016381-index.htm
2019-03-04Steven L. HoerterChief Commercial OfficerSell5,000.0068.00340,000.0010,941.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119016381/0001209191-19-016381-index.htm
2019-04-01Christopher BowdenChief Medical OfficerSell5,854.0066.03386,539.6211,384.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119023072/0001209191-19-023072-index.htm
2020-05-20Christopher BowdenChief Medical OfficerBuy3,583.0035.16125,978.2811,889.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000041/0001439222-20-000041-index.htm
2019-02-16Steven L. HoerterChief Commercial OfficerBuy2,750.0011,981.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119011494/0001209191-19-011494-index.htm
2019-02-16Andrew HirschChief Financial OfficerBuy2,750.0013,195.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119011491/0001209191-19-011491-index.htm
2019-05-31IAN T CLARKDirectorBuy1,400.001,400.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119033616/0001209191-19-033616-index.htm
2019-05-31JACQUALYN A FOUSEChief Executive OfficerBuy1,400.001,400.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119033620/0001209191-19-033620-index.htm
2019-05-31Maykin HoDirectorBuy1,400.001,400.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119033622/0001209191-19-033622-index.htm
2019-05-31Paul J ClancyDirectorBuy1,400.001,400.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119033614/0001209191-19-033614-index.htm
2019-01-20Andrew HirschChief Financial OfficerBuy15,000.0015,000.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119004961/0001209191-19-004961-index.htm
2019-01-20Steven L. HoerterChief Commercial OfficerBuy15,000.0015,000.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119004955/0001209191-19-004955-index.htm
2020-02-16Andrew HirschChief Financial OfficerBuy2,750.0015,127.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000016/0001439222-20-000016-index.htm
2020-02-04Christopher BowdenChief Medical OfficerBuy8,526.0035.16299,774.1615,841.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000005/0001439222-20-000005-index.htm
2019-03-01Steven L. HoerterChief Commercial OfficerBuy5,000.0039.76198,800.0015,941.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119016381/0001209191-19-016381-index.htm
2019-03-04Steven L. HoerterChief Commercial OfficerBuy5,000.0039.76198,800.0015,941.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119016381/0001209191-19-016381-index.htm
2020-02-04Christopher BowdenChief Medical OfficerSell14,191.0050.03709,962.961,650.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000005/0001439222-20-000005-index.htm
2020-02-04Christopher BowdenChief Medical OfficerSell35,447.0050.101,776,025.851,650.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000005/0001439222-20-000005-index.htm
2020-02-11Christopher BowdenChief Medical OfficerSell621.0050.0231,063.231,650.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000006/0001439222-20-000006-index.htm
2020-02-13Christopher BowdenChief Medical OfficerSell7,100.0050.16356,111.861,650.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000008/0001439222-20-000008-index.htm
2019-03-15Christopher BowdenChief Medical OfficerBuy10,000.0035.16351,600.0017,238.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119020288/0001209191-19-020288-index.htm
2019-04-01Christopher BowdenChief Medical OfficerBuy10,000.0035.16351,600.0017,238.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119023072/0001209191-19-023072-index.htm
2020-02-22Andrew HirschChief Financial OfficerBuy3,333.0017,574.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000024/0001439222-20-000024-index.htm
2019-11-12CORP /DE/ CELGENE10% Share HolderBuy403,225.0031.0012,499,975.001,777,824.00https://www.sec.gov/Archives/edgar/data/1439222/000110465919064171/0001104659-19-064171-index.htm
2019-12-26Carman AlensonPrincipal Accounting OfficerSell2,950.0050.09147,765.50184.00https://www.sec.gov/Archives/edgar/data/1439222/000143922219000030/0001439222-19-000030-index.htm
2020-02-20Carman AlensonPrincipal Accounting OfficerSell2,427.0053.37129,528.99184.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000020/0001439222-20-000020-index.htm
2020-02-26Carman AlensonPrincipal Accounting OfficerSell472.0047.1222,240.64184.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000025/0001439222-20-000025-index.htm
2020-03-02Carman AlensonPrincipal Accounting OfficerSell345.0047.3016,318.50184.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000027/0001439222-20-000027-index.htm
2020-09-02Carman AlensonPrincipal Accounting OfficerSell250.0039.939,982.50184.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000061/0001439222-20-000061-index.htm
2019-05-31David ScaddenDirectorBuy1,400.001,971.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119033626/0001209191-19-033626-index.htm
2020-04-13Andrew HirschChief Financial OfficerBuy5,387.0021,905.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000031/0001439222-20-000031-index.htm
2018-09-12JOHN MARAGANOREDirectorSell14,162.0071.741,015,981.8822,047.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118050824/0001209191-18-050824-index.htm
2020-02-11Christopher BowdenChief Medical OfficerBuy621.0035.1621,834.362,271.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000006/0001439222-20-000006-index.htm
2018-12-21Scott BillerChief Scientific OfficerBuy20,500.002.3447,918.7524,637.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118064102/0001209191-18-064102-index.htm
2020-04-22Andrew HirschChief Financial OfficerBuy5,893.0026,199.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000033/0001439222-20-000033-index.htm
2019-02-27Scott BillerChief Scientific OfficerSell9,000.0065.00585,000.0026,511.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119014933/0001209191-19-014933-index.htm
2019-03-05Scott BillerChief Scientific OfficerSell200.0068.2213,644.0026,511.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119017738/0001209191-19-017738-index.htm
2019-04-05Scott BillerChief Scientific OfficerSell599.0068.1240,803.8826,511.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119024105/0001209191-19-024105-index.htm
2019-03-05Scott BillerChief Scientific OfficerSell2,600.0067.73176,098.0026,711.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119017738/0001209191-19-017738-index.htm
2019-03-05Scott BillerChief Scientific OfficerBuy428.0031.6413,541.9226,939.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119017738/0001209191-19-017738-index.htm
2019-04-05Scott BillerChief Scientific OfficerSell2,401.0067.61162,331.6127,110.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119024105/0001209191-19-024105-index.htm
2019-02-16Scott BillerChief Scientific OfficerBuy2,750.0027,387.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119011486/0001209191-19-011486-index.htm
2019-02-27Scott BillerChief Scientific OfficerBuy1,766.000.47830.0228,277.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119014933/0001209191-19-014933-index.htm
2019-03-05Scott BillerChief Scientific OfficerSell200.0066.4513,290.0029,311.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119017738/0001209191-19-017738-index.htm
2019-03-05Scott BillerChief Scientific OfficerBuy2,572.0039.76102,262.7229,511.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119017738/0001209191-19-017738-index.htm
2019-04-05Scott BillerChief Scientific OfficerBuy3,000.0039.76119,280.0029,511.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119024105/0001209191-19-024105-index.htm
2020-05-29JOHN MARAGANOREDirectorBuy1,878.0030,172.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000050/0001439222-20-000050-index.htm
2019-02-27Scott BillerChief Scientific OfficerBuy4,154.009.0537,593.7032,431.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119014933/0001209191-19-014933-index.htm
2020-05-29IAN T CLARKDirectorBuy1,878.003,278.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000051/0001439222-20-000051-index.htm
2020-05-29Maykin HoDirectorBuy1,878.003,278.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000049/0001439222-20-000049-index.htm
2020-05-29Paul J ClancyDirectorBuy1,878.003,278.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000053/0001439222-20-000053-index.htm
2019-06-11Scott BillerChief Scientific OfficerBuy7,218.002.3416,872.0833,729.00https://www.sec.gov/Archives/edgar/data/1439222/000162828019007955/0001628280-19-007955-index.htm
2019-02-27Scott BillerChief Scientific OfficerBuy3,080.0031.6497,451.2035,511.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119014933/0001209191-19-014933-index.htm
2019-05-31Kaye I Foster-CheekDirectorBuy1,400.003,600.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119033618/0001209191-19-033618-index.htm
2018-09-11JOHN MARAGANOREDirectorSell2,400.0073.82177,168.0036,209.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118050824/0001209191-18-050824-index.htm
2020-02-05Christopher BowdenChief Medical OfficerBuy35,447.0035.161,246,316.5237,097.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000005/0001439222-20-000005-index.htm
2019-05-31JOHN MARAGANOREDirectorBuy1,400.0037,609.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119033625/0001209191-19-033625-index.htm
2020-02-16Carman AlensonPrincipal Accounting OfficerBuy2,800.003,774.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000019/0001439222-20-000019-index.htm
2019-02-21Carman AlensonPrincipal Accounting OfficerBuy3,300.003,812.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119012942/0001209191-19-012942-index.htm
2020-05-29David ScaddenDirectorBuy1,878.003,849.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000054/0001439222-20-000054-index.htm
2018-09-11JOHN MARAGANOREDirectorSell11,155.0072.52808,960.6038,609.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118050824/0001209191-18-050824-index.htm
2019-11-13JACQUALYN A FOUSEChief Executive OfficerBuy40,322.0031.001,249,982.0041,722.00https://www.sec.gov/Archives/edgar/data/1439222/000143922219000025/0001439222-19-000025-index.htm
2020-02-16Christopher BowdenChief Medical OfficerBuy2,750.004,400.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000018/0001439222-20-000018-index.htm
2018-10-05Scott BillerChief Scientific OfficerSell21.0071.771,507.1750,932.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118054513/0001209191-18-054513-index.htm
2018-11-05Scott BillerChief Scientific OfficerSell100.0071.427,142.0050,932.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118057556/0001209191-18-057556-index.htm
2018-10-05Scott BillerChief Scientific OfficerSell1,100.0071.0578,155.0050,953.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118054513/0001209191-18-054513-index.htm
2018-11-05Scott BillerChief Scientific OfficerSell700.0070.2349,161.0051,032.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118057556/0001209191-18-057556-index.htm
2018-11-05Scott BillerChief Scientific OfficerSell2,200.0069.44152,768.0051,732.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118057556/0001209191-18-057556-index.htm
2018-10-05Scott BillerChief Scientific OfficerSell979.0069.4768,011.1352,053.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118054513/0001209191-18-054513-index.htm
2018-10-05Scott BillerChief Scientific OfficerSell900.0068.5661,704.0053,032.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118054513/0001209191-18-054513-index.htm
2018-10-05Scott BillerChief Scientific OfficerBuy3,000.009.0527,150.0053,932.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118054513/0001209191-18-054513-index.htm
2018-11-05Scott BillerChief Scientific OfficerBuy3,000.009.0527,150.0053,932.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118057556/0001209191-18-057556-index.htm
2020-04-13JACQUALYN A FOUSEChief Executive OfficerBuy12,379.0054,101.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000030/0001439222-20-000030-index.htm
2020-05-29Kaye I Foster-CheekDirectorBuy1,878.005,478.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000052/0001439222-20-000052-index.htm
2020-04-13Bruce CarChief Scientific OfficerBuy6,874.006,874.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000029/0001439222-20-000029-index.htm
2020-02-22Christopher BowdenChief Medical OfficerBuy3,333.006,914.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000023/0001439222-20-000023-index.htm
2019-01-20Christopher BowdenChief Medical OfficerBuy6,265.007,189.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119004950/0001209191-19-004950-index.htm
2019-03-15Christopher BowdenChief Medical OfficerSell1,300.0064.6484,032.007,238.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119020288/0001209191-19-020288-index.htm
2019-04-01Christopher BowdenChief Medical OfficerSell100.0068.726,872.007,238.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119023072/0001209191-19-023072-index.htm
2018-09-05David P SchenkeinChief Executive OfficerBuy72,619.002.34169,928.4672,619.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118050064/0001209191-18-050064-index.htm
2019-04-01Christopher BowdenChief Medical OfficerSell1,500.0068.09102,135.007,338.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119023072/0001209191-19-023072-index.htm
2018-09-05David P SchenkeinChief Executive OfficerBuy2,500.0031.6479,100.0075,119.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118050064/0001209191-18-050064-index.htm
2019-02-16Carman AlensonPrincipal Accounting OfficerBuy790.00790.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119011483/0001209191-19-011483-index.htm
2019-02-16Christopher BowdenChief Medical OfficerBuy2,750.008,013.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119011489/0001209191-19-011489-index.htm
2020-05-20Christopher BowdenChief Medical OfficerSell3,583.0050.01179,200.168,306.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000041/0001439222-20-000041-index.htm
2018-09-10David P SchenkeinChief Executive OfficerBuy8,730.0031.64276,217.2083,849.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118050631/0001209191-18-050631-index.htm
2020-04-13Jonathan BillerChief Legal OfficerBuy8,523.008,523.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000032/0001439222-20-000032-index.htm
2019-03-15Christopher BowdenChief Medical OfficerSell8,700.0064.09557,583.008,538.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119020288/0001209191-19-020288-index.htm
2020-02-22Carman AlensonPrincipal Accounting OfficerBuy691.00875.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000021/0001439222-20-000021-index.htm
2020-02-13Christopher BowdenChief Medical OfficerBuy7,100.0035.16249,636.008,750.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000008/0001439222-20-000008-index.htm
2019-04-01Christopher BowdenChief Medical OfficerSell2,546.0066.85170,200.108,838.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119023072/0001209191-19-023072-index.htm
2019-02-16David P SchenkeinDirectorBuy8,125.0091,974.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119011498/0001209191-19-011498-index.htm
2020-02-16Carman AlensonPrincipal Accounting OfficerBuy790.00974.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000019/0001439222-20-000019-index.htm
2019-11-13David P SchenkeinDirectorBuy8,064.0031.00249,984.0097,567.00https://www.sec.gov/Archives/edgar/data/1439222/000143922219000023/0001439222-19-000023-index.htm